Growing R&D means more regulatory eyes on you. InfinixBio helps you scale without slipping—contact us to learn how we can help you.!
🔗 [https://t.co/rJY714s33e](https://t.co/NONBFjrdEp) #CRO#Biotech#Compliance
80% of biotech startups fail—but not all failures are scientific.
InfinixBio helps you de-risk execution, timelines, and data integrity from day one.
🔗 https://t.co/rJY714s33e #BiotechStrategy#CROpartner#DrugDev
Your pipeline is growing—can your CRO keep up?
InfinixBio scales with you: flexible capacity, fast onboarding, BSL II labs, ready to go.
🔗 https://t.co/FgVI5ciW0h #BiotechGrowth#DrugDev
Most R&D risks are preventable—if you plan like a scientist.
InfinixBio helps biotech teams build smarter protocols and avoid costly surprises.
🔗 https://t.co/FgVI5ciW0h #Biotech#DrugDev#RiskManagement
Ask this before signing with a CRO:
1. Who’s leading the science?
2. Can they scale with you?
3. How secure is the data?
We check all the boxes.
🔗 https://t.co/rJY714s33e #BiotechR&D #CROstrategy
Poor data = poor decisions.
InfinixBio ensures every study meets high scientific and regulatory standards, because rigor reduces risk.
🔗 https://t.co/FgVI5ciW0h
#DrugDev#CRO#Biotech
Growing your R&D pipeline?
InfinixBio helps you scale without sacrificing scientific quality—assay dev, compliance, timelines, all handled.
🔗 https://t.co/5WoMKnZ106#Biotech #DrugDev#ScaleSmart
Picking the wrong CRO? It can cost you data integrity and deadlines.
At InfinixBio, our PhD-led team delivers science-first, audit-ready research—no compromises.
🔗 https://t.co/FgVI5ciW0h #CRO#DrugDev
Biotech teams are moving fast, but not fast enough without the right support.
InfinixBio helps you scale smarter with scientific CRO teams that plug in fast and deliver.
🔗 https://t.co/rJY714s33e
#DrugDiscovery#BiotechCRO
SMA (Spinal Muscular Atrophy) breakthroughs: 6 promising therapies now in pipeline. Novartis' IT Zolgensma, Scholar Rock's muscle-targeting apitegromab & Biogen's enhanced Spinraza lead the way. Which approach will have the biggest impact on patients? https://t.co/0VgDtwMBpy
Colorectal cancer is highly preventable, yet it’s the 2nd leading cause of cancer deaths. Early detection saves lives. If you're 45+ or at risk, don’t wait—get screened. #ColorectalCancerAwareness#GetScreened
🔎 AstraZeneca’s Phase III results for camizestrant highlight the evolving role of SERDs in HR+/HER2- breast cancer. A pivotal moment for endocrine therapy. Full details:https://t.co/Mm96fHzUNS #Oncology#SERDs#CancerInnovation
Robust assays are essential for generating precise, reproducible data in early drug discovery. At InfinixBio, we collaborate with your team—from target characterization to lead optimization—to ensure strong scientific foundations.
https://t.co/xwNdN2Lr16
Preclinical research needs precision, not obstacles. 🔬 InfinixBio ensures seamless traceability, automated audit trails, and secure access—so your PK studies stay compliant and efficient. No bottlenecks, just reliable results.
🔍 Learn more: https://t.co/G49njAa7zC
On this International Day of Women and Girls in Science, we honor the women on our team and across the scientific community who prove that science has no boundaries. Their passion, dedication, and ingenuity drive innovation and inspire us all. #WomenInScience